Business

Enorama Pharma Q1 Operating Loss Narrows To SEK 10.9 Mln

Enorama Pharma Q1 Operating Loss Narrows To SEK 10.9 Mln

Enorama Pharma AbMay 20, 20264
Enorama Pharma Q1 Operating Loss Narrows To SEK 10.9 Mln

About this update from Enorama Pharma Ab

Enorama Pharma AB OMXSTO:ERMA:Q1 NET SALES AMOUNTED TO -109 KSEKQ1 OPERATING RESULT AMOUNTED TO -10,877 KSEK

View stock analysis, news, and events for Enorama Pharma Ab